Back to BIO 2015 for this week’s video, when Fintan Walton, CEO of PharmaVentures, caught up with BIA CEO Steve Bates on antimicrobial resistance (AMR).

In the interview, Steve discusses the UK government’s five-year AMR strategy, the on-going Jim O’Neill review and the BIA’s efforts to help tackle this global issue.


Do you have a video you would like the sector to see? Contact us.